Qilian International Holding Group Limited
NASDAQ:QLI
Overview | Financials
Company Name | Qilian International Holding Group Limited |
Symbol | QLI |
Currency | USD |
Price | 5.41 |
Market Cap | 38,681,500 |
Dividend Yield | 0% |
52-week-range | 1.776 - 6.69 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Zhanchang Xin |
Website | https://www.qlsyy.net |
An error occurred while fetching data.
About Qilian International Holding Group Limited
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD